Skip to main content

Mary Helen Foster

Professor of Medicine
Medicine, Nephrology
Duke Box 103015, Durham, NC 27710
Msrbii Second Floor, Rm 2018, 106 Research Drive, Durham, NC 27710

Overview


Research in the Foster Lab focuses on autoimmune glomerulonephritis, a major cause of acute and chronic kidney disease worldwide.

Our experiments explore the origins and regulation of the pathogenic immune  responses that underlie glomerulonephritis, and are designed to: identify tolerance mechanisms that regulate nephritogenic lymphocytes, with an emphasis on B cells and autoantibodies; determine the molecular basis of tolerance; identify defects in immune regulation and the contributions of genetic autoimmune predisposition; and identify environmental disease triggers. These experiments use novel models relevant to immune nephritis in both kidney-restricted and systemic autoimmunity (Goodpasture syndrome and systemic lupus erythematosus, respectively), that are amenable to mechanistic dissection using basic immunological, molecular biological, and proteomics approaches. An ultimate goal is to advance novel diagnostic and therapeutic approaches to improve the lives of patients.

Current Appointments & Affiliations


Professor of Medicine · 2019 - Present Medicine, Nephrology, Medicine
Member of the Duke Cancer Institute · 2000 - Present Duke Cancer Institute, Institutes and Centers

Recent Publications


Autoreactive B cells recruited to lungs by silica exposure contribute to local autoantibody production in autoimmune-prone BXSB and B cell receptor transgenic mice.

Journal Article Front Immunol · 2022 Occupational exposure to inhaled crystalline silica dust (cSiO2) is linked to systemic lupus erythematosus, rheumatoid arthritis, systemic sclerosis, and anti-neutrophil cytoplasmic autoantibody vasculitis. Each disease has a characteristic autoantibody pr ... Full text Link to item Cite

Emerging immunotherapies for autoimmune kidney disease.

Journal Article Hum Vaccin Immunother · 2019 Autoimmunity is a leading cause of chronic kidney disease and loss of native and transplanted kidneys. Conventional immunosuppressive therapies can be effective but are non-specific, noncurative, and risk serious side effects such as life-threatening infec ... Full text Link to item Cite
View All Publications

Recent Grants


Identification of Host-Specific Determinants of APOL1-associated COVAN

ResearchAdvisor · Awarded by National Institute of Diabetes and Digestive and Kidney Diseases · 2024 - 2029

U2C/TL1 NC KUH TRIO Administrative Core

ResearchCo Investigator · Awarded by University of North Carolina - Chapel Hill · 2023 - 2028

Gene-Environment Collaboration in Autoimmune Disease

ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2017 - 2023

View All Grants

Education, Training & Certifications


University of North Carolina, Chapel Hill · 1982 M.D.